Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNAMA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,672
Award facts
- Contract value 100% obligated
- $58,672.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $58,672 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pens. This non-competitive, firm fixed-price delivery order is expected to be completed by September 16, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the vendor's pharmaceutical supply relationship with DLA, which depends on major distributors to fulfill critical medication needs across military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical commodities to support Defense Health Agency operations and other federal healthcare systems globally. Dupixent is a biologic treatment used for conditions including atopic dermatitis, asthma, and chronic rhinosinusitis, making this delivery order reflective of DLA's responsibility to ensure the availability of specialty medications for military personnel and veterans.
Quick answers
Who was awarded contract SPE2DB25FNAMA?
SPE2DB25FNAMA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNAMA worth?
The government has obligated $58,672 on SPE2DB25FNAMA.
Is contract SPE2DB25FNAMA an order under another contract?
Yes. SPE2DB25FNAMA is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FNAMA competed?
The extent of competition for SPE2DB25FNAMA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award